Next-Generation Sequencing in Precision Medicine Market Deep Analysis Report 2025-2034

We collect cookies to enhance your browsing experience. Learn more X

# Next-Generation Sequencing in Precision Medicine Market Size, Share & Trends Analysis Distribution by Product & Service (NGS Services, Sequencing Instruments, Consumables & Reagents, Bioinformatics Software, and Library Preparation Kits), Technology, Application, End-use, and Segment Forecasts, 2025-2034

**Report Id: 3157** **Pages: 180** **Published: 13 August 2025** **Format: PDF / PPT / Excel / Power BI**

**Global Next-Generation Sequencing in Precision Medicine Market** Size is valued at **US$ 6.4 Bn in 2024** and is predicted to reach **US$ 28.6 Bn by the year 2034** at an **16.4% CAGR** during the **forecast period for 2025-2034**.

In the context of precision medicine, "next-generation sequencing" (NGS) refers to advanced DNA and RNA sequencing technologies that provide rapid, accurate, and comprehensive genetic material analysis. NGS may process millions of DNA fragments simultaneously, enabling researchers and clinicians to identify genetic variations, mutations, and biomarkers at a scale and speed never before achievable. NGS enables precision medicine by enhancing diagnosis, forecasting disease risk, and choosing the most effective treatments by tailoring medical interventions to each patient's distinct genomic profile. The market for next-generation sequencing in precision medicine is expected to grow significantly due to its revolutionary effects in providing precise, individualized diagnostics and treatments. Additionally, the demand for genomic-based therapy customization to an individual's genetic composition is being driven by the rising prevalence of uncommon diseases, cancer, and genetic abnormalities. The industry is expanding more quickly due to the growing use of next-generation sequencing in pharmacogenomics, oncology, and rare illness diagnosis, as well as improved bioinformatics, falling sequencing prices, and supportive government regulations. Moreover, pharmaceutical companies use NGS to create targeted medications and find biomarkers. The next-generation sequencing in the precision medicine market is growing due to regulatory backing for companion diagnostics.

## Competitive Landscape

Some of the Key Players in **Next-Generation Sequencing in Precision Medicine Market** are:
- Danaher
- Thermo Fisher Scientific
- Agilent Technologies
- Eurofins Scientific
- Pacific Biosciences (PacBio)
- Oxford Nanopore Technologies
- Takara Bio
- BGI Group (MGI Tech)
- QIAGEN
- Illumina
- Roche
- Merck KGaA
- BD (Becton, Dickinson and Company)
- 10x Genomics
- New England Biolabs
- Zymo Research
- Novogene
- Promega Corporation
- Revvity (formerly PerkinElmer)
- LGC Limited

## Market Segmentation

The next-generation sequencing in precision medicine market is segmented by product & service, technology, application, and end‑use. By product & service, the market is segmented into NGS services, sequencing instruments, consumables & reagents, bioinformatics software, and library preparation kits. By technology, the market is segmented into RNA sequencing, whole genome sequencing (WGS), targeted sequencing, whole exome sequencing (WES), and single‑cell sequencing. The application segment includes infectious disease, rare & inherited disorders, pharmacogenomics, oncology (cancer genomics), prenatal and reproductive health. By end‑use, the market is segmented into hospitals & clinics, diagnostic laboratories, biopharmaceutical companies, academic & research institutions, and CROs (contract research organizations).

## Sequencing Instruments Segment

Technology breakthroughs, growing use of high‑throughput platforms, and the growing need for customized treatments have all contributed to the sequencing instruments segment's greatest revenue share in the next‑generation sequencing in precision medicine market in 2024.

## Oncology Segment

In 2024, the next‑generation sequencing in the precision medicine market was driven by the oncology segment. NGS is widely employed in biomarker discovery, tailored treatment, and cancer diagnostics.

## Regional Dynamics

North America held the largest share in the next‑generation sequencing in precision medicine market because of the region's technologically advanced healthcare research framework and widespread use of NGS technology in precision medicine.

Asia‑Pacific is being pushed by rising healthcare spending and the rise in non‑communicable diseases (NCDs). APAC governments—including those of China, India, and Japan—are actively assisting genomic programs to promote precision medicine.

## Recent Developments

- **In Feb 2025:** Roche introduced its innovative sequencing by expansion (SBX) technology, creating a novel category of next‑generation sequencing.

## Report Scope

- **Report Attribute**
- **Specifications**
- **Market Size Value In 2024**: USD 6.4 Bn
- **Revenue Forecast In 2034**: USD 28.6 Bn
- **Growth Rate CAGR**: 16.4% from 2025 to 2034
- **Quantitative Units**: Representation of revenue in US$ Bn and CAGR from 2025 to 2034
- **Historic Year**: 2021 to 2024
- **Forecast Year**: 2025-2034
- **Report Coverage**: The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends
- **Segments Covered**: By Product & Service, By Technology, By Application, By End‑use, and By Region
- **Regional Scope**: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
- **Country Scope**: U.S.; Canada; Germany; The UK; France; Italy; Spain; Rest of Europe; China; Japan; India; South Korea; Southeast Asia; Rest of Asia Pacific; Brazil; Argentina; Mexico; Rest of Latin America; GCC Countries; South Africa; Rest of the Middle East and Africa
- **Competitive Landscape**: Danaher, Thermo Fisher Scientific, Agilent Technologies, Eurofins Scientific, Pacific Biosciences (PacBio), Oxford Nanopore Technologies, Takara Bio, BGI Group (MGI Tech), QIAGEN, Illumina, Roche, Merck KGaA, BD (Becton, Dickinson and Company), 10x Genomics, New England Biolabs, Zymo Research, Novogene, Promega Corporation, Revvity (formerly PerkinElmer), and LGC Limited

## Segmentation Details

- **By Product & Service**: NGS Services, Sequencing Instruments, Consumables & Reagents, Bioinformatics Software, Library Preparation Kits
- **By Technology**: RNA Sequencing, Whole Genome Sequencing (WGS), Targeted Sequencing, Whole Exome Sequencing (WES), Single‑Cell Sequencing
- **By Application**: Infectious Disease, Rare & Inherited Disorders, Pharmacogenomics, Oncology (Cancer Genomics), Prenatal and Reproductive Health
- **By End‑use**: Hospitals & Clinics, Diagnostic Laboratories, Biopharmaceutical Companies, Academic & Research Institutions, CROs (Contract Research Organizations)
- **By Region**: North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia‑Pacific (China, Japan, India, South Korea, Southeast Asia, Rest of Asia Pacific), Latin America (Brazil, Argentina, Mexico, Rest of Latin America), Middle East & Africa (GCC Countries, South Africa, Rest of the Middle East and Africa)

---

**Get Free PDF Brochure**

---

**Frequently Asked Questions**

- How big is the Next‑Generation Sequencing in Precision Medicine Market Size? Next‑Generation Sequencing in Precision Medicine Market Size is valued at US$ 1.3 Bn in 2024 and is predicted to reach US$ 7.5 Bn by the year 2034
- What is the Next‑Generation Sequencing in Precision Medicine Market Growth? Next‑Generation Sequencing in Precision Medicine Market is expected to grow at a 19.7% CAGR during the forecast period for 2025-2034.
- Who are the major players operating in the Next‑Generation Sequencing in Precision Medicine market? Major players in the Next‑Generation Sequencing in Precision Medicine market are Danaher, Thermo Fisher Scientific, Agilent Technologies, Eurofins Sc

---

**Related Reports**
- Nicorandil Market Size, Share and Forecast 2025-2034
- Stem Cell Therapy for Respiratory Disorders Market Size, Share and Forecast 2025-2034
- Psychedelic API Market Latest Report 2025
- Biologics Drug Discovery Market Research Report 2025

---

**Get FREE Sample Report**

---

**Contact Information**
- **Corporate Office**: Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
- **Sales Office (U.S.)**: 344 Grove St Unit #967 Jersey City, NJ 07302
- **Phone**: North America: +1 607 400-7072
- **Email**: [email protected]

---

© Copyright 2025, All rights reserved. Insightace Analytic Pvt.Ltd

Next-Generation Sequencing in Precision Medicine Market Deep Analysis Report 2025-2034

The article presents a comprehensive market analysis for next‑generation sequencing (NGS) technologies applied to precision medicine. It outlines the market size of US$6.4 bn in 2024, projects growth to US$28.6 bn by 2034 at a 16.4% CAGR, and highlights key players, market segmentation, regional dynamics, and recent developments such as Roche’s 2025 SBX technology. The report covers product & service, technology, application, end‑use, and regional segments and is available in multiple formats.